Avro Life Science Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Avro Life Science General Information

Description

Developer of a transdermal drug delivery system designed to provide slow-release medication. The company's system includes a polymer matrix skin patch that permits medicines to be absorbed directly into the bloodstream, enabling healthcare professionals to provide their patients with access to medication with a lower impact on the liver and improve health outcomes and quality of life.

Contact Information

Website
www.avrolifesci.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 200 University Avenue West
  • ESC 319
  • Waterloo, Ontario N2L 3G1
  • Canada
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 200 University Avenue West
  • ESC 319
  • Waterloo, Ontario N2L 3G1
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avro Life Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Out of Business 26-Jun-2025 Completed Out of Business
16. Accelerator/Incubator Completed Clinical Trials - Phase 2
15. Later Stage VC 01-Nov-2023 Completed Clinical Trials - Phase 2
14. Secondary Transaction - Private 24-Jan-2022 Completed Clinical Trials - Phase 2
13. Later Stage VC Completed Clinical Trials - Phase 2
12. Grant 05-May-2021 Completed Clinical Trials - Phase 2
11. Early Stage VC 01-Jan-2020 Completed Clinical Trials - Phase 2
10. Accelerator/Incubator 10-Jul-2018 Completed Clinical Trials - Phase 2
9. Early Stage VC 03-Apr-2018 $100K $254K Completed Pre-Clinical Trials
8. Accelerator/Incubator 19-Mar-2018 $120K $154K Completed Pre-Clinical Trials
To view Avro Life Science’s complete valuation and funding history, request access »

Avro Life Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avro Life Science Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto University
To view Avro Life Science’s complete investors history, request access »

Ready to get started?

Request a free trial

Avro Life Science FAQs

  • When was Avro Life Science founded?

    Avro Life Science was founded in 2016.

  • Where is Avro Life Science headquartered?

    Avro Life Science is headquartered in Waterloo, Canada.

  • What is the size of Avro Life Science?

    Avro Life Science has 19 total employees.

  • What industry is Avro Life Science in?

    Avro Life Science’s primary industry is Drug Discovery.

  • Is Avro Life Science a private or public company?

    Avro Life Science is a Private company.

  • What is Avro Life Science’s current revenue?

    The current revenue for Avro Life Science is .

  • How much funding has Avro Life Science raised over time?

    Avro Life Science has raised $254K.

  • Who are Avro Life Science’s investors?

    University of Toronto has invested in Avro Life Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process